Actemra and CP-690550 in Rheumatoid Arthritis: Can a Novel Agent Revolutionize Established Treatment Patterns? - On Demand

Based on our 2009 Physician & Payer Forum report The Rheumatoid Arthritis Biologics Landscape: Differentiation and Reimbursement in a Crowded Market, Decision Resources is offering an exclusive webinar entitled Actemra and CP-690550 in Rheumatoid Arthritis: Can a Novel Agent Revolutionize Established Treatment Patterns? Because this webinar features major report findings, it is ONLY available to purchasers of this Physician & Payer Forum report.

This webinar was held on November 18, 2009 and is only available to purchasers of this report.  Contact us  to learn how you can purchase this report and access a recorded playback of this event.  

Click here to view the invite.